EDGAR Filing Documents for 0001477932-23-006754

Form 8-K - Current report:

SEC Accession No. 0001477932-23-006754

Filing Date

2023-09-08

Accepted

2023-09-08 16:05:17

Documents

Period of Report

2023-09-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ivbt_8k.htm iXBRL	8-K	33999
2	SECURITIES PURCHASE AGREEMENT	ivbt_ex101.htm	EX-10.1	231775
3	SECURED CONVERTIBLE PROMISSORY NOTE	ivbt_ex102.htm	EX-10.2	128374
4	COMMON STOCK PURCHASE WARRANT	ivbt_ex103.htm	EX-10.3	98879
	Complete submission text file	0001477932-23-006754.txt		726463

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	ivbt-20230901.xsd	EX-101.SCH	5720
6	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ivbt-20230901_lab.xml	EX-101.LAB	13171
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ivbt-20230901_cal.xml	EX-101.CAL	898
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ivbt-20230901_pre.xml	EX-101.PRE	8249
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ivbt-20230901_def.xml	EX-101.DEF	2099
11	EXTRACTED XBRL INSTANCE DOCUMENT	ivbt_8k_htm.xml	XML	3279

Mailing Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866

Business Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866 929-459-4966

Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)